Track the 엔솔바이오사이언스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엔솔바이오사이언스 has logged 21 reports. The latest transaction was reported on 27 May 2026 (Purchase). Among the most active insiders: 형인우. All data is openly available.
21
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.